McGrath Yvonne 4
4 · iTeos Therapeutics, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
McGrath Yvonne
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-03-07+15,300→ 46,300 total - Award
Stock Option (Right to Buy)
2025-03-07+91,000→ 91,000 totalExercise: $7.05Exp: 2035-03-07→ Common Stock (91,000 underlying)
Footnotes (2)
- [F1]The reporting person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The shares of common stock underlying the RSUs will vest over 4 years: 25% will vest on March 7, 2026 and the remainder will vest equally, on an annual basis, over the remaining 3 years, subject to the reporting person's continued service to the issuer.
- [F2]This stock option shall vest over four years, with 25% vesting on March 7, 2026 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the issuer.